Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Equity (2016 - 2025)

Regenxbio has reported Return on Equity over the past 11 years, most recently at 1.47% for Q4 2025.

  • Quarterly results put Return on Equity at 1.47% for Q4 2025, down 66.0% from a year ago — trailing twelve months through Dec 2025 was 1.47% (down 66.0% YoY), and the annual figure for FY2025 was 1.07%, down 28.0%.
  • Return on Equity for Q4 2025 was 1.47% at Regenxbio, down from 0.95% in the prior quarter.
  • Over the last five years, Return on Equity for RGNX hit a ceiling of 0.21% in Q4 2021 and a floor of 1.47% in Q4 2025.
  • Median Return on Equity over the past 5 years was 0.15% (2021), compared with a mean of 0.35%.
  • Biggest five-year swings in Return on Equity: surged 34bps in 2022 and later tumbled -79bps in 2024.
  • Regenxbio's Return on Equity stood at 0.21% in 2021, then tumbled by -100bps to 0.0% in 2022, then tumbled by -2109223bps to 0.78% in 2023, then dropped by -4bps to 0.81% in 2024, then plummeted by -81bps to 1.47% in 2025.
  • The last three reported values for Return on Equity were 1.47% (Q4 2025), 0.95% (Q3 2025), and 0.72% (Q2 2025) per Business Quant data.